Cargando…
Exploring the choices and outcomes of older patients with advanced kidney disease
A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004–2016) of a large single centre...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286495/ https://www.ncbi.nlm.nih.gov/pubmed/32520955 http://dx.doi.org/10.1371/journal.pone.0234309 |
_version_ | 1783544889109118976 |
---|---|
author | Pyart, Rhodri Aggett, Justine Goodland, Annwen Jones, Hayley Prichard, Alison Pugh, Julia Thomas, Nerys Roberts, Gareth |
author_facet | Pyart, Rhodri Aggett, Justine Goodland, Annwen Jones, Hayley Prichard, Alison Pugh, Julia Thomas, Nerys Roberts, Gareth |
author_sort | Pyart, Rhodri |
collection | PubMed |
description | A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004–2016) of a large single centre in the United Kingdom (1,216 patients), age, sex, comorbidity, poverty and frailty were used to predict choice of renal replacement therapy (RRT) over maximum conservative management (MCM). The impact of patient choice of RRT versus MCM was used to predict survival from the time of choice using multivariable Cox proportional hazards regression. Older age, female sex, greater poverty and greater frailty were associated with choosing MCM, whilst comorbidity had no significant impact on choice. At 5 years of follow up, 49% of all patients had died without receiving RRT. Over 70% of the patients choosing MCM died with better kidney function than the median level at which those starting RRT initiated treatment. Frailty and age were better predictors of survival than comorbidity and in patients with at least moderate frailty, RRT offered no survival benefit over MCM. In conclusion, analysing outcomes from the time of choice may improve shared decision making. Frailty should be routinely assessed and collected and further work may help predict which patients are unlikely to survive or progress to end stage renal disease and may not need to be burdened with making a pre-dialysis choice. |
format | Online Article Text |
id | pubmed-7286495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-72864952020-06-17 Exploring the choices and outcomes of older patients with advanced kidney disease Pyart, Rhodri Aggett, Justine Goodland, Annwen Jones, Hayley Prichard, Alison Pugh, Julia Thomas, Nerys Roberts, Gareth PLoS One Research Article A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004–2016) of a large single centre in the United Kingdom (1,216 patients), age, sex, comorbidity, poverty and frailty were used to predict choice of renal replacement therapy (RRT) over maximum conservative management (MCM). The impact of patient choice of RRT versus MCM was used to predict survival from the time of choice using multivariable Cox proportional hazards regression. Older age, female sex, greater poverty and greater frailty were associated with choosing MCM, whilst comorbidity had no significant impact on choice. At 5 years of follow up, 49% of all patients had died without receiving RRT. Over 70% of the patients choosing MCM died with better kidney function than the median level at which those starting RRT initiated treatment. Frailty and age were better predictors of survival than comorbidity and in patients with at least moderate frailty, RRT offered no survival benefit over MCM. In conclusion, analysing outcomes from the time of choice may improve shared decision making. Frailty should be routinely assessed and collected and further work may help predict which patients are unlikely to survive or progress to end stage renal disease and may not need to be burdened with making a pre-dialysis choice. Public Library of Science 2020-06-10 /pmc/articles/PMC7286495/ /pubmed/32520955 http://dx.doi.org/10.1371/journal.pone.0234309 Text en © 2020 Pyart et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Pyart, Rhodri Aggett, Justine Goodland, Annwen Jones, Hayley Prichard, Alison Pugh, Julia Thomas, Nerys Roberts, Gareth Exploring the choices and outcomes of older patients with advanced kidney disease |
title | Exploring the choices and outcomes of older patients with advanced kidney disease |
title_full | Exploring the choices and outcomes of older patients with advanced kidney disease |
title_fullStr | Exploring the choices and outcomes of older patients with advanced kidney disease |
title_full_unstemmed | Exploring the choices and outcomes of older patients with advanced kidney disease |
title_short | Exploring the choices and outcomes of older patients with advanced kidney disease |
title_sort | exploring the choices and outcomes of older patients with advanced kidney disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286495/ https://www.ncbi.nlm.nih.gov/pubmed/32520955 http://dx.doi.org/10.1371/journal.pone.0234309 |
work_keys_str_mv | AT pyartrhodri exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease AT aggettjustine exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease AT goodlandannwen exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease AT joneshayley exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease AT prichardalison exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease AT pughjulia exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease AT thomasnerys exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease AT robertsgareth exploringthechoicesandoutcomesofolderpatientswithadvancedkidneydisease |